TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability
Cancer Medicine · 2023
DOI: 10.1002/cam4.5683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Xin Meng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Lamin Type A, Ovarian Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Ovarian cancer (OC) is one of the fatal gynecologic malignancies. However, there are no effective prognostic or therapeutic indicators for OC. Herein, we aim to reveal the potential function of targeting protein for Xklp2 (TPX2) in OC progression.
Methods
Immunohistochemical and bioinformatic analyses were used to evaluate the level of TPX2 in OC samples. Effects of TPX2 on cell proliferation, cell apoptosis and ROS production were evaluated in vivo and in vitro. Mass spectrometry, Co‐IP and immunofluorescence assays were performed to identify and verify protein‐protein interactions.
Results
Our data showed that pathological overexpression (OE) of the TPX2 in OC could manifest a poor prognosis. Functional studies demonstrated that TPX2 silencing led to the suppression of cell proliferation in vitro and in vivo through an increase in reactive oxygen species (ROS) level and apoptosis, while TPX2 OE exhibited the opposite effect. Furthermore, by mass spectrometric analysis, we identified a novel interacting partner, Lamin A/C, for TPX2. Mechanistically, TPX2 regulated Lamin A/C's stability by modulating the level of phospho‐Lamin A/C (Ser 22).
Conclusion
Our findings thus suggest that TPX2 may be a promising therapeutic target for OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
ORCID-Profile: Renquan Lu
Zitieren
APA
Meng, X., Cao, J., Zheng, H., Ma, X., Wang, Y., Tong, Y., Xie, S., Lu, R., & Guo, L. (2023). TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability. Cancer Medicine. https://doi.org/10.1002/cam4.5683
Vancouver
Meng X, Cao J, Zheng H, Ma X, Wang Y, Tong Y, et al. TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability. Cancer Medicine. 2023. doi:10.1002/cam4.5683
BibTeX
@article{Meng2023,
author = {Meng, Xin and Cao, Jiazhen and Zheng, Hui and Ma, Xiaolu and Wang, Yanchun and Tong, Ying and Xie, Suhong and Lu, Renquan and Guo, Lin},
title = {TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5683}
}
EUVIMED